It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The neuromodulatory subcortical nuclei within the isodendritic core (IdC) are the earliest sites of tauopathy in Alzheimer’s disease (AD). They project broadly throughout the brain’s white matter. We investigated the relationship between IdC microstructure and whole-brain white matter microstructure to better understand early neuropathological changes in AD. Using multiparametric quantitative magnetic resonance imaging we observed two covariance patterns between IdC and white matter microstructure in 133 cognitively unimpaired older adults (age 67.9 ± 5.3 years) with familial risk for AD. IdC integrity related to 1) whole-brain neurite density, and 2) neurite orientation dispersion in white matter tracts known to be affected early in AD. Pattern 2 was associated with CSF concentration of phosphorylated-tau, indicating AD specificity. Apolipoprotein-E4 carriers expressed both patterns more strongly than non-carriers. IdC microstructure variation is reflected in white matter, particularly in AD-affected tracts, highlighting an early mechanism of pathological development.
The isodendritic core is a group of neuromodulatory nuclei with diffuse projections. Here the authors describe associations between the microstructural integrity of the isodendritic core and whole-brain white matter in humans, and its relationship to Apolipoprotein-E4 carrier status.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
2 Concordia University, Department of Physics, Montreal, Canada (GRID:grid.410319.e) (ISNI:0000 0004 1936 8630); Montreal Heart Institute, Montreal, Canada (GRID:grid.482476.b) (ISNI:0000 0000 8995 9090); Concordia University, School of Health, Montreal, Canada (GRID:grid.410319.e) (ISNI:0000 0004 1936 8630)
3 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Biomedical Engineering, McGill, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
4 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
5 York University, Department of Psychology, Toronto, Canada (GRID:grid.21100.32) (ISNI:0000 0004 1936 9430)
6 Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268)
7 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268)
8 Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268); McGill University, Department of Psychiatry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
9 McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268); McGill University, Department of Psychiatry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
10 Western University, Department of Physiology & Pharmacology, Western Institute for Neuroscience, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884)
11 McGill University, Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, McConnell Brain Imaging Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); Douglas Mental Health University Institute—Research Center, Verdun, Canada (GRID:grid.412078.8) (ISNI:0000 0001 2353 5268); McGill University, Department of Psychiatry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)